2N1G

Structure of C-terminal domain of human polymerase Rev1 in complex with PolD3 RIR-motif

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.5 mM [U-100% 13C; U-100% 15N] Rev1-CT, 0.5-0.8 mM PolD3, 50 mM potassium phosphate, 100 mM sodium chloride, 2 mM DTT, 0.5 mM EDTA	90% H2O/10% D2O	100	7.0	ambient	288
2	2D 1H-13C HSQC	0.5 mM [U-100% 13C; U-100% 15N] Rev1-CT, 0.5-0.8 mM PolD3, 50 mM potassium phosphate, 100 mM sodium chloride, 2 mM DTT, 0.5 mM EDTA	90% H2O/10% D2O	100	7.0	ambient	288
3	3D HNCO	0.5 mM [U-100% 13C; U-100% 15N] Rev1-CT, 0.5-0.8 mM PolD3, 50 mM potassium phosphate, 100 mM sodium chloride, 2 mM DTT, 0.5 mM EDTA	90% H2O/10% D2O	100	7.0	ambient	288
4	3D HNCACB	0.5 mM [U-100% 13C; U-100% 15N] Rev1-CT, 0.5-0.8 mM PolD3, 50 mM potassium phosphate, 100 mM sodium chloride, 2 mM DTT, 0.5 mM EDTA	90% H2O/10% D2O	100	7.0	ambient	288
5	3D HBHA(CO)NH	0.5 mM [U-100% 13C; U-100% 15N] Rev1-CT, 0.5-0.8 mM PolD3, 50 mM potassium phosphate, 100 mM sodium chloride, 2 mM DTT, 0.5 mM EDTA	90% H2O/10% D2O	100	7.0	ambient	288
6	3D HCCH-TOCSY	0.5 mM [U-100% 13C; U-100% 15N] Rev1-CT, 0.5-0.8 mM PolD3, 50 mM potassium phosphate, 100 mM sodium chloride, 2 mM DTT, 0.5 mM EDTA	90% H2O/10% D2O	100	7.0	ambient	288
7	3D CCH-TOCSY	0.5 mM [U-100% 13C; U-100% 15N] Rev1-CT, 0.5-0.8 mM PolD3, 50 mM potassium phosphate, 100 mM sodium chloride, 2 mM DTT, 0.5 mM EDTA	90% H2O/10% D2O	100	7.0	ambient	288
8	3D 1H-13C NOESY	0.5 mM [U-100% 13C; U-100% 15N] Rev1-CT, 0.5-0.8 mM PolD3, 50 mM potassium phosphate, 100 mM sodium chloride, 2 mM DTT, 0.5 mM EDTA	90% H2O/10% D2O	100	7.0	ambient	288
9	3D 1H-15N NOESY	0.5 mM [U-100% 13C; U-100% 15N] Rev1-CT, 0.5-0.8 mM PolD3, 50 mM potassium phosphate, 100 mM sodium chloride, 2 mM DTT, 0.5 mM EDTA	90% H2O/10% D2O	100	7.0	ambient	288
10	2D 1H-1H (filt.) TOCSY	0.5 mM [U-100% 13C; U-100% 15N] Rev1-CT, 0.5-0.8 mM PolD3, 50 mM potassium phosphate, 100 mM sodium chloride, 2 mM DTT, 0.5 mM EDTA	90% H2O/10% D2O	100	7.0	ambient	288
11	2D 1H-1H (filt.) NOESY	0.5 mM [U-100% 13C; U-100% 15N] Rev1-CT, 0.5-0.8 mM PolD3, 50 mM potassium phosphate, 100 mM sodium chloride, 2 mM DTT, 0.5 mM EDTA	90% H2O/10% D2O	100	7.0	ambient	288
12	3D 1H-13C (CNfilt.) NOESY	0.5 mM [U-100% 13C; U-100% 15N] Rev1-CT, 0.5-0.8 mM PolD3, 50 mM potassium phosphate, 100 mM sodium chloride, 2 mM DTT, 0.5 mM EDTA	90% H2O/10% D2O	100	7.0	ambient	288
13	3D 1H-15N (CNfilt.) NOESY	0.5 mM [U-100% 13C; U-100% 15N] Rev1-CT, 0.5-0.8 mM PolD3, 50 mM potassium phosphate, 100 mM sodium chloride, 2 mM DTT, 0.5 mM EDTA	90% H2O/10% D2O	100	7.0	ambient	288

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	Avance	500
2	Varian	Avance	800

NMR Refinement
Method	Details	Software
simulated annealing		CYANA

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (fewest violations)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
2	processing	NMRPipe	5.5	Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3	chemical shift assignment	CARA	1.9.0	Keller and Wuthrich
4	chemical shift calculation	CARA	1.9.0	Keller and Wuthrich
5	peak picking	CARA	1.9.0	Keller and Wuthrich
6	refinement	ABACUS_(CNS)		Brunger, Adams, Clore, Gros, Nilges and Read
7	data analysis	TALOS	2.20	Cornilescu, Delaglio and Bax

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.